Patent details
EP0979292 Title: GENE CONSTRUCT ENCODING A HETEROLOGOUS PRODRUG-ACTIVATING ENZYME AND A CELL TARGETING MOIETY
Basic Information
- Publication number:
- EP0979292
- PCT Application Number:
- PCT/GB/1998/001294
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP989193800
- PCT Publication Number:
- WO/1998/051787
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- GENE CONSTRUCT ENCODING A HETEROLOGOUS PRODRUG-ACTIVATING ENZYME AND A CELL TARGETING MOIETY
- French Title of Invention:
- CONSTRUCTION DE GENE CODANT POUR UNE ENZYME HETEROLOGUE CAPABLE D'ACTIVER UNE PRODROGUE ET UN GROUPEMENT VISANT UNE CELLULE
- German Title of Invention:
- GENKONSTRUKT DAS FÜR EIN HETEROLOGES ÄPRODRUGÄ-AKTIVIERENDES ENZYM UND FÜR EIN ZELLGERICHTES TEIL KODIERT
- SPC Number:
Dates
- Filing date:
- 05/05/1998
- Grant date:
- 29/10/2008
- EP Publication Date:
- 29/10/2008
- PCT Publication Date:
- 19/11/1998
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/02/2000
- EP B1 Publication Date:
- 29/10/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/05/2009
- Expiration date:
- 05/05/2018
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/05/1998
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
1
- Name:
- EMERY Stephen, Charles Zeneca Pharmaceuticals
- Address:
- United Kingdom (GB)
2
- Name:
- BLAKEY David, Charles Zeneca Pharmaceuticals
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 9709421
- Priority Date:
- 10/05/1997
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- C12N 15/62;
| Filing date | Document type | Number of pages |
|---|